H. Al-Abdulkarim

Disease-Related Costs Published in The Middle East and North Africa Region: Systematic Review and Analysis of Transferability

M. Péntek, L. Gulácsi, Z. Zrubka, 2022, PharmacoEconomics.

COVID-19 and Saudi Arabia public financing of prescription drugs: An opportunity for reform

Y. AlRuthia, B. Balkhi, H. Al-Abdulkarim, 2020 .

Digital Biomarker–Based Interventions: Systematic Review of Systematic Reviews

M. Péntek, L. Gulácsi, Z. Zrubka, 2022, Journal of Medical Internet Research.

Demographic Characteristics and Status of Vaccinated Individuals with a History of COVID-19 Infection Pre- or Post-Vaccination: A Descriptive Study of a Nationally Representative Sample in Saudi Arabia

K. Alabdulkareem, O. Almohammed, Y. Asiri, 2022, Vaccines.

Pharmacy and Therapeutics Committee Preparedness Plan for COVID-19.

M. Harbi, Laila Carolina Abu Esba, H. Al-Abdulkarim, 2020, Global journal on quality and safety in healthcare.

An Institutional Guide for Formulary Decisions of Biosimilars

C. Yousef, Mansoor A Khan, Sherine Ismail, 2022, Hospital pharmacy.

Real-World Impact of Switching From Insulin Glargine (Lantus®) to Basaglar® and Potential Cost Saving in a Large Public Healthcare System in Saudi Arabia

S. Alghnam, Y. AlRuthia, H. Al-Abdulkarim, 2022, Frontiers in Public Health.

Cost Consequence Analysis of the Management of Hyperkalemia by Patiromer and Optimization of Renin-Angiotensin-Aldosterone System Inhibitors Therapy in Chronic Kidney Disease Patients in Saudi Arabia

A. Meunier, L. Floros, H. Al-Abdulkarim, 2022, Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia.